Contents
The Huntsville physician urine testing fraud case concerned tests ordered for billing and unused in treatment, according to the criminal information filed in September 2016. Prosecutors charged the physician who operated Chronic Pain Care Services with defrauding Medicare and Blue Cross Blue Shield of Alabama through unnecessary urine drug tests. For someone inside a pain practice, the revealing details are the standing orders, who reviewed the results, and whether anything changed when the results came back.
The information alleged that urine testing accounted for approximately 80% of the physician’s paid claims to those insurers from January 2011 through March 2013. It described a practice in Huntsville, Alabama, where insurance coverage determined the testing method and the opportunity to bill changed how often patients were tested. The testing revenue and the treatment decision had come apart, prosecutors alleged.
Insured patients at Chronic Pain Care Services had to undergo two automated urine tests at every appointment, according to the criminal information. Both used immunoassay testing on laboratory machines called chemistry analyzers. Uninsured patients received a cheaper dip-stick test, known as a point-of-care or quick-cup test. Neither group could choose the other method.
The information gives the financial incentive in plain numbers. During the alleged scheme, Medicare sometimes paid up to approximately $200 for the first automated test and up to approximately $300 for the second. Quick-cup reimbursement was approximately $20. Those were payments for testing methods that the information said the practice selected according to what it could bill.
The alleged change in frequency followed the equipment purchases. Before the physician began directly billing for tests on chemistry analyzers, he tested patients on a randomized basis. After buying two analyzers in 2011, he began ordering tests for every insured patient at scheduled visits and certain prescription-refill pickups. The information alleged that the ability to bill directly drove that change. A billing employee could see the insurer and the claim. A laboratory employee could see which test the same patient actually received.
According to the information, the physician’s Preferred Physician Laboratory Agreement with Blue Cross Blue Shield of Alabama required medically necessary tests and the same standards of service as for other patients. Prosecutors alleged that insurance coverage instead determined which testing method patients received.
According to the criminal information, staff at Chronic Pain Care Services had standing orders to run both automated tests regardless of patient history or need. Both tests used immunoassays.
The second test allegedly went ahead even when the first found no drug to measure. The information described the contradiction directly:
The second test, the purpose of which was ostensibly to provide more precise information regarding the level of a drug in a patient’s system, was conducted even if the results of the first test showed that the drug in question was absent from the patient’s system.
United States of America v. Aggarwal, criminal information, paragraph 37
Timing raised another problem. Prosecutors alleged that initial screens were often run after insured patients had already received their prescriptions, even though rapid results were supposed to inform that prescribing decision. We see the absurdity: the tests kept coming, but their answers did not have to matter.
According to the criminal information, the physician did not review all the urine-test results. He delegated review to an unlicensed, untrained staff member and instructed that person to initial the results using his initials. An insider who knew who actually handled the results could explain something the initialed report concealed.
The information also alleged that the physician often ignored results showing illicit or nonprescribed drugs, or the absence of prescribed drugs. Patients with repeated abnormal results were not referred to drug counseling or addiction treatment. In some instances, their dosages increased. The alleged failure reached the treatment decision after the laboratory had done its work.
That distinction matters in a business whose product is information. The laboratory chapter in Health Care Administration: Managing Organized Delivery Systems, published by Jones and Bartlett in 2011, describes connecting laboratory findings with other clinical information, including medication profiles. It also calls for reliable physician-utilization data and management reports that track the impact of laboratory results on clinical outcomes. Counting tests captures the activity. It misses what anyone did with the answers.
According to the criminal information, the office saw approximately 80 to 145 patients a day in 2012. Initial visits typically lasted five minutes or less, and follow-ups two minutes or less. The physician was responsible for every patient’s care plan and saw most patients himself.
Prosecutors further alleged that he obtained no medical records from patients’ other providers, treated patients only with controlled substances and often prescribed the drugs patients requested. The information said he continued prescribing despite drug-use warnings and abnormal test results. For a clinical or billing insider, the connection is concrete: the practice generated testing claims alongside prescriptions, while allegedly leaving the information those tests produced out of the care.
Coastal Spine and Pain agreed to a $7.4 million settlement in a separate civil case involving routine quantitative urine testing after qualitative screens. In its August 2016 announcement, the Justice Department described allegations that Physicians Group Services, doing business as Coastal Spine and Pain, ordered the additional tests without patient-specific medical necessity. The recurring question is why the next test was ordered for that patient.
A whistleblower’s complaint against National Spine and Pain Centers alleged another way to keep testing volume high: rewards for the offices that performed the most drug tests. The complaint put the incentive in terms a medical assistant or office manager would recognize:
National Spine rewards the office that administers the highest volume of drug tests each week with gift cards, cash prizes, and free meals at restaurants.
These civil allegations show how an insider’s view can extend beyond the test report. A standing order, an office reward or a rule requiring an additional test can explain why the same billing pattern keeps appearing. In the Huntsville criminal information, prosecutors located that decision in the physician’s test orders and ability to bill for them.
For suspected urine-testing fraud, the useful evidence connects the order, the result and the government claim. In this case, the information identified insurance coverage, testing method, standing orders, timing, the person reviewing results and the response to abnormal findings. Those details explain how a medically unnecessary test could become a paid Medicare claim.
The person behind the initials matters as much as the initials themselves. Medical records must identify their author, as the Medicare Program Integrity Manual explains. A staff member’s account of who reviewed a result can therefore add something distinct from the report, just as the billing team’s account can connect that report to the payer.
We work with practice and laboratory insiders to shape those connections into a possible civil whistleblower case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Your knowledge of who set the testing rules and what happened to the results is where that conversation starts.
If you worked with mandatory urine-test orders, initialed results or claims that ignored what happened in the exam room, talk with our whistleblower experts about the practice you know. We connect your clinical and billing knowledge to a potential Medicare fraud case and bring in healthcare fraud whistleblower lawyers who understand laboratory testing. We stay beside you as that inside knowledge becomes the case we pursue together.